NCT03861637View on ClinicalTrials.gov

Impact of Full Correction of PTA in Renal Transplant Recipients

NACompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

January 20, 2015

Primary Completion Date

December 20, 2018

Study Completion Date

December 20, 2018

Conditions

Anemia

Interventions

OTHER

ESA for correction of PTA to 12-13g/dl

To assess the impact of full correction of chronic PTA(to near normal values) on cardiovascular system and quality of life in renal transplant recipients with stable graft function using erythropoietin stimulating agents in comparison to partially treated PTA with HB level between 12-13g/dl.

All Listed Sponsors

lead

Hamid Al-Essa Organ Transplant Center

OTHER_GOV

NCT03861637 - Impact of Full Correction of PTA in Renal Transplant Recipients | Biotech Hunter | Biotech Hunter